MedPath

A study to assess Biological imaging before, during, and after Simultaneous Modulated Accelerated Radiation Therapy in head and neck squamous cell carcinoma .

Not Applicable
Conditions
Health Condition 1: null- Head Neck Squamous Cell Carcinoma
Registration Number
CTRI/2013/09/003988
Lead Sponsor
Tata Memorial Centre Tata Memorial Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
20
Inclusion Criteria

1.Patients >18 yrs and <=65 yrs

2.Biopsy proven squamous carcinoma of the oropharynx, larynx or hypopharynx

3.T stage â?? T1 to T3

4.N stage â?? N1 to N2c

5.Planned for definitive non- surgical treatment (radiotherapy with or without systemic chemotherapy)

6.ECOG PS 0 to1

Exclusion Criteria

1.Metastatic disease

2.Prior history of malignancy

3.Prior treatment interventions for the index malignancy (lymph node biopsies allowed)

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To standardise the image acquisition with F-MISO PET.Timepoint: pre RT
Secondary Outcome Measures
NameTimeMethod
To assess changes in tumour characteristics using serial functional imaging with PET-CT (FDG & F-MISO) and MRI (DWI & DSC) in patients with HNSCC over a course of fractionated (chemo) radiotherapy.Timepoint: 9-12 months
© Copyright 2025. All Rights Reserved by MedPath